11 completed, 2 active not recruiting, 2 recruiting, 1 unknown. 10 Not applicable, 3 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 7, Active not recruiting 2, Unknown 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 4 | 2 | Recruiting 1, Withdrawn 1 |
Follow Stage 0 Breast Cancer: new trials by email Literature Review of Stage 0 Breast Cancer trials Research Report on Stage 0 Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Revaree Plus in People With Breast Cancer Revaree Plus - Breast Cancer, Stage 0 Breast Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2025-06-20 | 2026-02-06 |
| Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma External Beam Accelerated Partial Breast Irradiation - Breast Carcinoma, Breast Cancer | Not applicable | Active not recruiting | Washington University School of Medicine | 134 | 2021-08-12 | 2026-05-06 |
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. Hypofractionated radiotherapy - Ductal Breast Carcinoma in Situ, Invasive Breast Cancer | Not applicable | Active not recruiting | Coordinación de Investigación en Salud, Mexico | 72 | 2021-04-26 | 2026-03-23 |
| Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Anastrozole, Exemestane, Laboratory Biomarker Analysis - HER2/Neu Negative, Invasive Breast Carcinoma | Phase 4 | Withdrawn | Fred Hutchinson Cancer Center | 2018-09-01 | 2018-12-27 | |
| The PREDICT Registry: Treatment recommendation surveys, 7-gene biosignature - DCIS, Stage 0 Breast Cancer | Recruiting | PreludeDx | 3000 | 2018-02-27 | 2026-04-17 | |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer Hypofractionated Radiation Therapy - Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma | Phase 2 | Completed | University of Utah | 102 | 2017-12-12 | 2025-12-30 |
| Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer Biopsy, Questionnaire Administration, Ultrasound Tomography - Peripheral Neuropathy, Stage 0 Breast Cancer | Not applicable | Completed | Wake Forest University Health Sciences | 20 | 2017-05-11 | 2024-04-08 |
| Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) Educational Intervention, Laboratory Biomarker Analysis, Meditation Therapy - Cancer Survivor, Early-Stage Breast Carcinoma | Not applicable | Unknown | Jonsson Comprehensive Cancer Center | 96 | 2017-02-20 | 2022-07-21 |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration - Febrile Neutropenia, Stage 0 Breast Cancer | Not applicable | Completed | SWOG Cancer Research Network | 3665 | 2016-10-07 | 2022-10-20 |
| Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer Biospecimen Collection, Functional Magnetic Resonance Imaging, Questionnaire Administration - Healthy Subject, Stage 0 Breast Cancer | Completed | Stanford University | 178 | 2016-08-01 | 2022-07-27 | |
| Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors Computer-Assisted Cognitive Training, Questionnaire Administration, Standard Follow-Up Care - Cancer Survivor, Stage 0 Breast Cancer | Not applicable | Completed | Fred Hutchinson Cancer Center | 15 | 2016-05-01 | 2017-12-13 |
| eHealth Weight Loss Program in African American Breast Cancer Survivors Behavioral Dietary Intervention, Exercise Intervention, Activity Monitoring Device - Cancer Survivor, Stage IA Breast Cancer | Not applicable | Completed | Rutgers, The State University of New Jersey | 35 | 2016-01-08 | 2021-04-13 |
| Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer Curcumin-based Gel, Dermatologic Complications Management, Laboratory Biomarker Analysis - Breast Carcinoma, Pain | Phase 2 | Completed | Gary Morrow | 191 | 2015-10-13 | 2017-11-06 |
| Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy Telapristone Acetate, Placebo, Laboratory Biomarker Analysis - BRCA1 Mutation Carrier, BRCA2 Mutation Carrier | Phase 2 | Completed | Northwestern University | 67 | 2015-10-01 | 2023-02-22 |
| Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy Internet-Based Intervention, Survey Administration - Stage 0 Breast Cancer, Stage I Breast Cancer | Not applicable | Completed | Rutgers, The State University of New Jersey | 94 | 2015-09-24 | 2021-04-20 |
| Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors Educational Intervention, Exercise Intervention, Quality-of-Life Assessment - Cancer Survivor, Stage 0 Breast Cancer | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 25 | 2015-05-14 | 2022-03-10 |
| Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer Telephone-Based Intervention, Survey Administration, Laboratory Biomarker Analysis - Stage IA Breast Cancer, Stage IB Breast Cancer | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 39 | 2015-03-26 | 2025-06-29 |
Breast Carcinoma In Situ (17) · Breast Neoplasms (16) · Carcinoma, Intraductal, Noninfiltrating (4) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Depression (1) · Febrile Neutropenia (1) · Pain (1) · Peripheral Nervous System Diseases (1) · Radiodermatitis (1)
Breast Diseases (17) · Carcinoma (17) · Carcinoma in Situ (17) · Neoplasms (17) · Neoplasms by Histologic Type (17) · Neoplasms by Site (17) · Neoplasms, Glandular and Epithelial (17) · Skin Diseases (17) · Skin and Connective Tissue Diseases (17) · Adenocarcinoma (4) · Neoplasms, Ductal, Lobular, and Medullary (4) · Agranulocytosis (1) · Behavior (1) · Behavioral Symptoms (1) · Breast Neoplasms (1)
Early Intervention, Educational (2) · Educational Status (2) · Methods (2) · Radiation Dose Hypofractionation (2) · Anastrozole (1) · Biopsy (1) · Curcumin (1) · Letrozole (1) · Meditation (1) · Monitoring, Physiologic (1) · Radiotherapy, Conformal (1) · Radiotherapy, Intensity-Modulated (1) · Tamoxifen (1) · Toremifene (1) · exemestane (1)
Fred Hutchinson Cancer Center (2) · Ohio State University Comprehensive Cancer Center (2) · Rutgers, The State University of New Jersey (2) · Coordinación de Investigación en Salud, Mexico (1) · Gary Morrow (1) · Jonsson Comprehensive Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · Northwestern University (1) · PreludeDx (1) · SWOG Cancer Research Network (1) · Stanford University (1) · University of Utah (1) · Wake Forest University Health Sciences (1) · Washington University School of Medicine (1)
United States (16) · Mexico (1) · Puerto Rico (1)
David Spiegel (1) · Fernando H Castillo-Lopez, Phy. (1) · Gary Morrow (1) · Imran Zoberi, M.D. (1) · Jeanne Ferrante (1) · Kathleen Shannon Dorcy (1) · Maryam Lustberg, MD (1) · Matthew Poppe (1) · Michelle Naughton, PhD, MPH (1) · Pat Borgen, MD (1) · Pat W Whitworth, MD (1) · Patricia Ganz (1) · Rachel Rabinovitch, MD (1) · Roy Strowd (1) · Scott Ramsey (1)
PMID 30535101, PMID 33997922, PMID 34406839, PMID 35365139, PMID 36130057, PMID 36228177, PMID 36279134, PMID 37083300, PMID 37770704, PMID 37788414, PMID 38916700, PMID 38917400, PMID 39132946, PMID 40314623
P30CA015704 (2), P30CA012197 (1), P30CA072720 (1), R01CA200977 (1), R21CA178648 (1), R21CA187643 (1), R21CA191431 (1), U01CA197282 (1), UG1CA189961 (1), UG1CA189974 (1)